Dear Colleagues: Welcome to the July–August 2015 issue of Innovations in Clinical Neuroscience. We begin this issue with a review article by Cole et al titled, “Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date.” Here the authors examined the literature regarding TMS efficacy in relieving […]
Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. First, I would like to call your attention to the accompanying supplement to this issue of the journal, a compendium of abstracts from the 2014 CNS Summit poster presentations. Each year, the CNS Summit brings together drug development leaders from pharma, research sites, […]
Dear Colleagues: Welcome to the March–April 2015 issue of Innovations in Clinical Neuroscience (ICNS). First, I would like to call to your attention the supplement that accompanies this issue of ICNS, presented by the International Society for CNS Clinical Trials and Methodology (ISCTM), of which ICNS is the official publication.
Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting advances in the development and use of central nervous system (CNS) therapeutic agents. Over the past few years, this forum has specifically addressed the strategic […]
Dear Colleagues: Welcome to the January-February 2015 issue of Innovations in Clinical Neuroscience and to the beginning of our 12th year of publication. Over the years, we have sought to not only provide you with information on the latest, evidence-based treatment techniques for your patients, but also with information on how these new treatments are […]
Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug development guidance papers created by the collaborative efforts of the clinicians, investigators, industry scientists, and other entities involved in drug development who participate in the […]
Editor’s Message: Special Edition of ICNS Covers Multiple Aspects of Assessment of Suicidal Ideation and Behavior
Dear Colleagues: Every year, over 800,000 people commit suicide worldwide, with over 40,000 of these deaths occurring annually in the United States. There are many more who attempt it.[1,2] A United States Centers for Disease Control and Prevention (CDC) report indicated that nearly 500,000 people in the United States visit a hospital annually for injuries […]
Dear Colleagues: Welcome to the July-August issue of Innovations in Clinical Neuroscience. We start this issue with an original research article titled, “Transcultural Adaptation of GRID Hamilton Rating Scale For Depression (GRID-HAMD) to Brazilian Portuguese and Evaluation of the Impact of Training Upon Inter-Rater Reliability,” by Araújo et al. In this study, the authors sought […]
Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. This month we open with an interesting contribution by Lehrer and Lorenze titled “Anosognosia in Schizophrenia: Hidden in Plain Sight,” as part of the ongoing “Psychiatry and Neurology” article series.
Dear Colleagues: Welcome to the March–April issue of Innovations in Clinical Neuroscience. In this issue, we are pleased to introduce a new commentary series on the communication of clinical trial results by Dr. Leslie Citrome. In this month’s installment titled, “The Sunshine Act and Transfers of Value: Impact on Non-industry Authorship,” Dr. Citrome discusses the use […]